Stonepine Capital Management, LLC - 10 Dec 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. Ordinary Shares (QNRX)

Filing Manager
Stonepine Capital Management, LLC
Reporting Manager
Stonepine Capital Management, LLC
Security
Quoin Pharmaceuticals, Ltd. Ordinary Shares
Symbol
QNRX
Shares outstanding
30,615,414 shares
Disclosed Ownership
3,030,926 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
16 Dec 2025, 16:04:26 UTC
Date of event
10 Dec 2025
Next filing
02 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Stonepine Capital Management, LLC 9.9% 3,030,926 0 3,030,926 /s/ Jon M. Plexico Managing Member
Stonepine Capital, L.P. 9.9% 3,030,926 0 3,030,926 /s/ Jon M. Plexico Managing Member of the General Partner, Stonepine GP, LLC
Stonepine GP, LLC 9.9% 3,030,926 0 3,030,926 /s/ Jon M. Plexico Managing Member
Jon M. Plexico 9.9% 3,030,926 0 3,030,926 /s/ Jon M. Plexico Reporting person